Sunday, August 20, 2017

Psych News

New Mental Health Czar Criticized Agency She Will Head
On August 3, The U.S. Senate confirmed psychiatrist Elinore F. McCance-Katz as the Department of Health and Human Services
first Assistant Secretary for Mental Health and Substance Abuse, a post created by the 21st Century Cures Act. McCance-Katz will oversee the Substance Abuse and Mental Health and Services Administration (SAMHSA) where she once worked, and will coordinate substance abuse and mental health programs in more than 100 federal agencies. In an editorial last year, http://www.psychiatrictimes.com/depression/federal-government-ignores-treatment-needs-americans-serious-mental-illness McCance-Katz criticized SAMHSA for, among other things, the "…questioning by some at SAMHSA as to whether mental disorders even exist — for example, is psychosis just a 'different way of thinking for some experiencing stress?'"
"Electroceuticals" Mind Control in Sheep's Clothing
Last year, the Wall Street Journal https://www.wallstreetdaily.com/2016/03/10/electroceuticals-glaxosmithkline-gsk/ heralded the arrival of "electroceuticals" a portmanteau of "electronics" and "pharmaceuticals" coined by big pharma's GlaxoSmithKline. Electroceuticals would implant electronic devices about the size of a grain of rice into the brain to "modulate neural signals" directly. While electronic pacemakers, defibrillators and cochlear implants have proven helpful to patients, billions are now being bet on electronic brain implants as a replacement for the heavy hand of psychopharmaceuticals with their no-better-than-placebo results, skyrocketing cost, unpredictable and often lethal side effects, and competition by generic drug equivalents. But nothing about electroceuticals is new except the name.
Everybody Must Get Stoned
Now that 26 states and the District of Columbia have some form of legalized marijuana, the psychiatric establishment is warning that use of the substance can lead to mood swings, paranoia, psychosis, and addiction
http://www.psychiatrictimes.com/substance-use-disorder/cannabis-induced-psychosis-review To treat these symptoms, antipsychotics such as Olanzapine and Haloperidol are recommended. Olanzapine is also used for schizophrenia, and side effects include: confusion, coma, mental changes, uncontrolled muscle movements, trouble talking, aggression, dizziness, high blood pressure, and seizures." https://www.drugs.com/cdi/olanzapine.html Haloperidol has side effects including hallucinations; mental or mood changes, abnormal thinking, anxiety, depression https://www.drugs.com/cdi/haloperidol.html , involuntary grimacing, sucking, and smacking of lips, etc. https://www.nami.org/Learn-More/Treatment/Mental-Health-Medications/Haloperidol-(Haldol) Is marijuana a gateway drug? The first director of the National Institute on Drug Abuse says it is. 

No comments:

Post a Comment